Truist Financial Corp increased its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 21.0% during the 4th quarter, according to its most recent disclosure with the SEC. The ...

Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations. Looking ...

Fintel reports that on February 28, 2025, Barrington Research downgraded their outlook for LeMaitre Vascular (NasdaqGM:LMAT) ...

Learn more about whether LeMaitre Vascular, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor ...

Oppenheimer has downgraded LeMaitre Vascular (NASDAQ:LMAT) to perform from outperform as its price target of $93 has been met ...

Lake Street raised the firm’s price target on LeMaitre (LMAT) to $110 from $105 and keeps a Buy rating on the shares, telling investors that ...

LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q4 2024 results, announced an increased quarterly dividend ...

BURLINGTON, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q4 2024 results, announced an increased quarterly dividend ...

For the current quarter ending in March, LeMaitre said it expects revenue in the range of $56.7 million to $58.7 million. The company expects full-year earnings to be $2.15 to $2.32 per share, with ...

Medical device company LeMaitre Vascular (NASDAQ:LMAT) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose ...

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) will likely be releasing its earnings data after the market closes on ...